Mumps Therapeutics - Pipeline Analysis, Clinical Trials & Results

Mumps is a transmissible disease caused by the mumps virus and is characterized by swelling of glands in neck and face. Some of the symptoms of this disease are headache, fever, tiredness, loss of appetite, and muscle ache.

Request to Get Sample Pages at:  https://www.pharmaproff.com/request-sample/1067

The disease can be transferred from an infected person through coughing; sneezing; and sharing items, such as razors and utensils. According to the Centers for Disease Control and Prevention, a study from January 2017 to July 2017 covering 46 states of the U.S., estimated that around 3,886 people have mumps infection.

Make Enquiry Before Buying the Report:https://www.pharmaproff.com/enquiry/1067 

The complications associated with mumps include encephalitis, orchitis, mastitis, meningitis, and deafness. Daiichi Sankyo Co. Ltd. is in the process of developing VN-0102 as a measles-mumps-rubella vaccine for the treatment of mumps. Cadila Healthcare Limited is also involved in the development of drug candidates for the treatment of this disease.

Access Detailed Report Summary: https://www.pharmaproff.com/report/mumps-therapeutics-pipeline-analysis

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.

Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

Read More

Middle East Respiratory Syndrome (MERS) Therapeutics Pipeline Analysis

Middle East respiratory syndrome (MERS) is a viral respiratory disease caused by a coronavirus (MERS-CoV). Coronaviruses are a type of viruses that affect the respiratory tract of mammals, including humans. Human coronaviruses usually cause mild to moderate cold-like illnesses. However, MERS-CoV is different from any other coronavirus previously found in people.

Request to Get Sample Pages at: https://www.pharmaproff.com/request-sample/1066

The infected patients may have mild symptoms or no symptoms at all, but most people infected with MERS-CoV develop severe respiratory illness, fever, cough, and shortness of breath. Some patients have reported to have gastrointestinal symptoms like diarrhea and nausea/vomiting; and kidney failure. MERS-CoV is known to spread from an infected person to others through respiratory secretions like coughing. However, the precise way in which this virus spreads has not been well understood yet. Some of the companies having drugs in the MERS syndrome pipeline includes Atriva Therapeutics GmbH and Inovio Pharmaceuticals Inc. are known to be involved in MERS pipeline.

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.

Make Enquiry Before Buying the Report: https://www.pharmaproff.com/enquiry/1066

Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

Read More

Klebsiella Infections Therapeutics Pipeline Analysis, Clinical Trials & Results

Klebsiella infections include different types of infections like bloodstream infections; pneumonia; wound or surgical site infections; and meningitis, caused by the Klebsiella bacteria. The symptoms associated with these infections are high fevers, chills, cough, and shortness of breath.

Request to Get Sample Pages at:   https://www.pharmaproff.com/request-sample/1065

Hospitalized patients undergoing treatment for other conditions may be susceptible to these infections. In healthcare settings, patients who require long courses of antibiotics, or are treated with devices like ventilators or intravenous catheters are at a high risk of developing these infections.

Although these infections are often treated with antibiotics, but some Klebsiella bacteria may be resistant to certain types of antibiotics. Arsanis Inc. is in the process of developing ASN300 as a monoclonal antibody for the treatment of Klebsiella infections.

Make Enquiry Before Buying the Report: https://www.pharmaproff.com/enquiry/1065

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.

Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

Read More

Impetigo Therapeutics: Drug Development Pipeline Analysis

Impetigo is a common bacterial infection caused by different kinds of bacteria, including streptococcus and staphylococcus. It is a contagious disease and begins with appearance of red sores on any part of the body, which eventually changes to blisters on the body.

Request to Get Sample Pages at:  

                                                   https://www.pharmaproff.com/request-sample/1064

Impetigo is more common in warm and humid weather, is known to easily transmit in crowded settings like schools and day care. Impetigo can be treated by topical antibiotics, oral antibiotics and some home remedies. It is mostly found in children, especially boys, but may also affect adults if they have a weak immune system. Foamix Pharmaceuticals is in the process of developing FMX102 for the treatment of impetigo. Destiny Pharma plc is also involved in the pipeline for impetigo therapeutics.

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.

Make Enquiry Before Buying the Report:

                                                                    https://www.pharmaproff.com/enquiry/1064

Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

Read More